News
Administration of Erdosteine After Severe Course of COVID-19 in the Early Period After Patient Discharge From Medical Facility
Erdosteine is a mucomodulatory drug used in the therapy of various acute and chronic respiratory diseases. Its mechanism of action is considered complex based on available evidence, encompassing antioxidant and antibacterial effects along with its mucolytic effect. Two clinical studies assessed changes in respiratory distress parameters and quality of life in patients taking this medication in the early period after discharge from medical facilities where they were hospitalized for severe COVID-19 (respiratory failure, pneumonia).
Even a Single Epileptic Seizure is Too Much
Focal epileptic seizures resistant to pharmacotherapy represent an ongoing unmet medical need.
Insufficiently Controlled Epilepsy Reduces Quality and Length of Life
The effects of uncontrolled epilepsy far exceed the moment of a seizure, having a substantial…
Clinical and Microbiological Effect of L. reuteri in the Treatment of Chronic Periodontitis
The Journal of Clinical Periodontology published the results of a study evaluating the effect of…
How to Detect COPD Early in Primary Care?
Chronic obstructive pulmonary disease (COPD) can be present even in individuals without obvious…
News in COPD Treatment Recommendations in a Nutshell
We present an overview of the most important changes in the annually updated recommendations of the…
STADA Brings Innovative Drug for Treatment of Advanced Parkinson's Disease to Czech Republic
STADA PHARMA CZ is introducing a new system for continuous delivery of 3 active substances for the…
Optimization of Enoxaparin Dosing in Obese Patients
Obesity is a risk factor for venous thromboembolism; however, there is uncertainty regarding the…
Enoxaparin in the Treatment of Pulmonary Embolism in a Morbidly Obese Patient – Case Report
The number of patients suffering from overweight and obesity has been steadily increasing in recent…
Treatment with Dupilumab in Severe Corticosteroid-Dependent Bronchial Asthma – A Case Study
We present the case of a 36-year-old woman with severe corticosteroid-dependent asthma with…